COMPANY Data
My FAVORITES

Movers and SHAKERS

Ticker | NVCN (Nasdaq) |
Current Price | $6.58 ↑ 0.48 |
Market Cap | 17.96M |
Price Target | *Refer to Report* |
Volume | 28.92k |
52wk Range | $4.64 - $28.25 |
ADVANCED MARKET DATA |

Advanced Market Data
Neovasc Inc. (NVCN)Overview
As of April 24, 2020, Noble Capital Markets research on Neovasc is published under ticker symbols (NVCN and NVCN:CA). The price target is in USD and based on ticker symbol NVCN. Research reports dated prior to April 24, 2020 may not follow these guidelines and could account for a variance in the price target. Neovasc Inc is a specialty medical device company. The company develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara for the transcatheter treatment of mitral valve disease and the Neovasc Reducer for the treatment of refractory angina. Neovasc is developing the Tiara for the treatment of mitral valve disease. Neovasc operates its business in one segment.
- Industry/Sector Report
- Corporate Presentation
- Corporate Events
- Press Releases/News Feed
- ChannelCAST Videos [2]
- Senior Equity Research Analyst
- Corporate Filings
Neovasc Inc. Corporate Filings
Neovasc Inc. Corporate Events
Neovasc Inc. Press Releases / News Feed
Channelchek
Not available
Channelchek
No reports available
Noble Capital Markets Analyst
FINRA licenses 7, 63, 86, 87.
Full Bio & Coverage List